跳至主要内容
临床试验/IRCT201508201556N79
IRCT201508201556N79已完成3 期

celecoxib in the treatment of mild to moderate depression in patients with colon cancer: A randomized placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 1-Confirmation of colon cancer;2-receiving chemotherapy 3- score lower than 20 in Hamilton Rating Scale for depression 4-Mild to moderate major depressive disorder based on DSM-5
  • Exclusin criteria: 1-psychosis or other psychiatric disorder 2-Receiving psychotropic medications,3- receiving any antidepressants during past one month or ECT during past two months 4-history of cardiovascular disease , 5-pregnancy or breast feeding, 6-thyroid diseases

排除标准

  • 未提供

研究者

相似试验